Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review

Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review

Temozolomide (TMZ) is an alkylating chemotherapeutic agent that has recently been used in some cases as a new therapeutic tool for pituitary carcinomas and aggressive pituitary adenomas. In this report, we present the case of effective TMZ treatment in a 42-year-old man with ACTH-secreting carcinoma...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorenzo Curtò, Maria L. Torre, Francesco Ferraù, Vincenzo Pitini, Giuseppe Altavilla, Francesca Granata, Marcello Longo, Leo J. Hofland, Francesco Trimarchi, Salvatore Cannavò
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2010.210
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items